Tobramycin FDA Approved Drugs
BETHKIS [TobramycinC18H37N5O9]
RX
- 300mg/4ml (inhalation solution)
Chiesi Usa IncOct 12, 2012
- Management of cystic fibrosis patients.
TOBI PODHALER [TobramycinC18H37N5O9]
RX
- 28mg (inhalation powder)
NovartisMar 22, 2013
- Treatment of cystic fibrosis patients with pseudomonas aeruginosa.
TOBRADEX [DexamethasoneC22H29FO5 : TobramycinC18H37N5O9]
RX
- 0.1% : 0.3% (ophthalmic suspension/drops)
Novartis Pharms CorpAug 18, 1988
TOBRADEX ST [DexamethasoneC22H29FO5 : TobramycinC18H37N5O9]
RX
- 0.05% : 0.3% (ophthalmic suspension/drops)
Novartis Pharms CorpFeb 13, 2009
- Use of a combination of tobramycin and dexamethasone to treat ocular inflammation where an infection or risk of infection exists.
TOBRAMYCIN [TobramycinC18H37N5O9]
RX
- 0.3% (ophthalmic solution/drops)
300mg/5ml (inhalation solution)
Bausch And LombNov 29, 1993
Fera PharmsSep 11, 2001
Somerset Theraps LlcJun 28, 2017
Akorn IncMay 28, 2014
Amneal PharmsJul 13, 2015
Lupin AtlantisMar 22, 2017
Teva Pharms UsaOct 10, 2013
Fera PharmsSep 11, 2001
Somerset Theraps LlcJun 28, 2017
Akorn IncMay 28, 2014
Amneal PharmsJul 13, 2015
Lupin AtlantisMar 22, 2017
Teva Pharms UsaOct 10, 2013
TOBRAMYCIN AND DEXAMETHASONE [DexamethasoneC22H29FO5 : TobramycinC18H37N5O9]
RX
- 0.1% : 0.3% (ophthalmic suspension/drops)
Bausch And LombOct 27, 1999
TOBRAMYCIN SULFATE [Tobramycin Sulfate2C18H37N5O95H2O4S]
RX
- eq 1.2gm base/vial (injection injectable)
eq 10mg base/ml (injection injectable)
eq 40mg base/ml (injection injectable)
Fresenius Kabi UsaJul 13, 2004
X Gen PharmsAug 17, 2001
Xellia Pharms ApsSep 16, 2014
HospiraApr 30, 1991
AkornSep 16, 2014
ClarisJul 1, 2016
Mylan Labs LtdMar 11, 2008
Teva Pharms UsaJan 30, 1992
West-ward Pharms IntApr 26, 1991
X Gen PharmsAug 17, 2001
Xellia Pharms ApsSep 16, 2014
HospiraApr 30, 1991
AkornSep 16, 2014
ClarisJul 1, 2016
Mylan Labs LtdMar 11, 2008
Teva Pharms UsaJan 30, 1992
West-ward Pharms IntApr 26, 1991
TOBRAMYCIN SULFATE (PHARMACY BULK) [Tobramycin Sulfate2C18H37N5O95H2O4S]
RX
- eq 40mg base/ml (injection injectable)
Fresenius Kabi UsaNov 29, 2002
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER [Tobramycin Sulfate2C18H37N5O95H2O4S]
RX
- eq 1.2mg base/ml (injection injectable)
eq 1.6mg base/ml (injection injectable)
eq 80mg base/100ml (injection injectable)
HospiraJul 31, 1990
TOBREX [TobramycinC18H37N5O9]
RX
- 0.3% (ophthalmic solution/drops)
Novartis Pharms CorpApproved Prior To Jan 1, 1982
Sandoz IncDec 13, 1984
Sandoz IncDec 13, 1984
ZYLET [Loteprednol EtabonateC24H31ClO7 : TobramycinC18H37N5O9]
RX
- 0.5% : 0.3% (ophthalmic suspension/drops)
Bausch And LombDec 14, 2004
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.